The 10th Santorini conference: Systems medicine, personalised health and therapy. "The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind ", Santorini, Greece, 23-26 May 2022.

Autor: Visvikis-Siest S; EA_1122 IGE-PCV, Université de Lorraine, Nancy, France., Stathopoulou MG; Team 10: Control of Gene Expression, INSERM U, Centre Méditerranéen de Médecine Moléculaire C3M, Nice, France., Sunder-Plassmann R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Alizadeh BZ; Unit of Personalized Medicine, Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherland., Barouki R; Université de Paris, Inserm unit 1124 (T3S), Paris, France., Chatzaki E; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.; Institute of Agri-Food and Life Sciences, Hellenic Mediterranean University Research Centre, Heraklion, Crete, Greece., Dagher G; Inserm, Paris, France.; Graz Medical University, Graz, Austria.; Milano-Bicocca University, Milan, Italy.; Beijing Academy of Sciences, Beijing, China., Dedoussis G; Department of Nutrition and Dietetics, Harokopio University of Athens, Athens, Greece., Deloukas P; 13 William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Haliassos A; EurSpLM, ESEAP, The Greek Proficiency Testing Scheme for Clinical Laboratories Athens, Athens, Greece., Hiegel BB; EA_1122 IGE-PCV, Université de Lorraine, Nancy, France., Manolopoulos V; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.; Clinical Pharmacology and Pharmacogenetics Unit, Academic General Hospital of Alexandroupolis, Alexandroupolis, Greece., Masson C; EA_1122 IGE-PCV, Université de Lorraine, Nancy, France., Paré G; Population Health Research Institute, Genetic and Molecular Epidemiology Laboratory, McMaster University, Hamilton, ON, Canada., Paulmichl M; Privatklinik Maria Hilf, Klagenfurt, Austria., Petrelis AM; EA_1122 IGE-PCV, Université de Lorraine, Nancy, France.; Digitsole, Nancy, France., Sipeky C; UCB Pharma, Translational Medicine, Precision Medicine and Biomarkers, Genetics, Braine-l'Alleud, Belgium., Süsleyici B; Marmara University, Faculty of Sciences and Letters, Department of Molecular Biology, Istanbul, Türkiye., Weryha G; EA_1122 IGE-PCV, Université de Lorraine, Nancy, France., Chenchik A; Cellecta, Inc, Mountain View, CA, United States., Diehl P; Cellecta, Inc, Mountain View, CA, United States., Everts RE; Agena Bioscience, San Diego, CA, United States., Haushofer A; Inst. f. Med. u. Chem. Labordiagnostik, Klinikum Wels-Grieskirchen GmbH, Wels, Austria., Lamont J; Randox Laboratories Limited, Crumlin, Co. Antrim, United Kingdom., Mercado R; Cellecta, Inc, Mountain View, CA, United States., Meyer H; Agena Bioscience, Hamburg, Germany., Munoz-Galeano H; HMG Systems Engineering GmbH, Fürth, Germany., Murray H; Randox Laboratories Limited, Crumlin, Co. Antrim, United Kingdom., Nhat F; Thermo Fisher Scientific, San Francisco, CA, United States., Nofziger C; PharmGenetix GmbH, Anif/Niederalm, Austria., Schnitzel W; PharmGenetix GmbH, Anif/Niederalm, Austria., Kanoni S; 13 William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Jazyk: angličtina
Zdroj: Frontiers in genetics [Front Genet] 2023 Mar 09; Vol. 14, pp. 1171131. Date of Electronic Publication: 2023 Mar 09 (Print Publication: 2023).
DOI: 10.3389/fgene.2023.1171131
Abstrakt: Competing Interests: Author AP was employed by the company Digitsole. Author CS was employed by the company UCB Pharma, Author AC, PD, RM were employed by the company Cellecta, Authors RE was employed by the company Agena (United States), Author AH was employed by the company Randox, Authors HM was employed by the company Agena (Germany), Author FN was employed by the company Thermo Fisher Scientific, Author CN, WS were employed by the company PharmGenetix. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Databáze: MEDLINE